Acute otitis media, or ear infection, is the most common ailment among kids of preschool age and younger in the U.S., primarily because these children have immature middle-ear drainage systems, higher exposure to respiratory illnesses and undeveloped immune systems.
And because it's also the most common reason for antibiotic use among all children, the costs associated with acute otitis media (AOM) are under more scrutiny than ever by health care and government administrators, especially given today's political and economic climate, strained health-care resources and cost-containment efforts.
While estimates of the economic impact of AOM have been formulated in the past, a new study by UCLA and Harvard University researchers is the first to use a national population database that gives a direct, head-to-head comparison of expenditures for pediatric patients diagnosed with ear infections and similar patients without ear infections.
The findings show that AOM is associated with significant increases in direct costs incurred by consumers and the health care system. With its high prevalence across the U.S., pediatric AOM accounts for approximately $2.88 billion in added health care expenses annually and is a significant health-care utilization concern.
The research is published in the current edition of the journal The Laryngoscope.
"Although the annual incidence of ear infection may be declining in the U.S., the number of kids affected remains high, and the public health implications of AOM are substantial," said study co-author Dr. Nina Shapiro, director of pediatric otolaryngology at Mattel Children's Hospital UCLA and a professor of head and neck surgery at the David Geffen School of Medicine at UCLA. "As our health care system continues to be vigorously discussed around the nation, efforts to control costs and allocate resources appropriately are of prime importance."
For the study, the researchers examined records of pediatric patients under the age of 18 culled from the 2009 Medical Expenditure Panel Survey, a national survey conducted by the Agency for Health Research and Quality which serves a benchmark data-set specifically designed for the assessment of health care costs.
